News Formal

Last of 3 Zymergen founders to leave as company preps for Ginkgo Bioworks merger with 80 more layoffs - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Before $DNA merger, $ZY outlines another 80 job cuts — including the last of 3 founders — that halve its workforce over the past year

founded Zymergen in April 2013. Hoffman, who was CEO, left the company last August. Dean, who was Zymergen's vice president of operations, exited last October.

Serber will receive a cash lump-sum payment equal to 12 months of his annual base salary — which was $353,485 last year — as well as his full target annual bonus. The company also will continue to pay its premium on healthcare coverage for Serber and his dependents for up to 12 months and full vesting of unvested equity awards.

Still to be worked out is what happens to Zymergen's big real estate portfolio in the East Bay, accumulated as its employee numbers ballooned in the two years prior to its implosion.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 78. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Every Company Will Need a Chief Metaverse Officer | HackerNoonEvery company will be a metaverse company, and every company will need a Chief Metaverse Officer.
La source: hackernoon - 🏆 532. / 51 Lire la suite »

Last of 3 Zymergen founders to leave as company preps for Ginkgo Bioworks merger with 80 more layoffs - San Francisco Business TimesChief Scientific Officer Zach Serber, former operations chief Jed Dean and former CEO Josh Hoffman took Zymergen from an April 2013 startup to an 800-employee company with a $525 million 2021 IPO before it imploded a year ago.
La source: SFBusinessTimes - 🏆 78. / 68 Lire la suite »